Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Christos, Chouaïd"'
Autor:
Jean-Bernard Auliac, Pascal-Alexandre Thomas, Olivier Bylicki, Florian Guisier, Hubert Curcio, AlainVegnenègre, Aurelie Swalduz, Marie Wislez, Jacques Le Treut, Chantal Decroisette, Victor Basse, Lionel Falchero, Gonzague De Chabot, Diane Moreau, Eric Huchot, Audrey Lupo Mansuet, Helene Blons, Christos Chouaïd, Laurent Greillier
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Few epidemiological data are available on surgically treated Caucasian patients with non-small-cell lung cancers (NSCLCs) harboring epidermal growth factor receptor ( EGFR ) mutations. The main objective of this study was to describe, in
Externí odkaz:
https://doaj.org/article/39e6f0c59e0e4157ac626aaebfa1f7dd
Autor:
Jonas Poucineau, Myriam Khlat, Nathanaël Lapidus, Maude Espagnacq, Christos Chouaïd, Tristan Delory, Sophie Le Coeur
Publikováno v:
International Journal of Public Health, Vol 69 (2024)
Objectives: We investigated the mortality patterns of chronic obstructive pulmonary disease (COPD) patients in France relative to a control population, comparing year 2020 to pre-pandemic years 2017–2019.Methods: COPD patient and sex, age and resid
Externí odkaz:
https://doaj.org/article/01cf8bbd7b804573a583e235602c6eae
Autor:
Valentine Grumberg, Christos Chouaïd, Anne-Françoise Gaudin, Christophe Le Tourneau, Aurélien Marabelle, Isabelle Bongiovanni-Delarozière, François-Emery Cotté, Isabelle Borget
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEIn 2020, the French National Authority for Health (Haute Autorité de Santé) published a methodologic guide called organizational impact (OI) cartography to define and structure assessment of the OI of health technologies. As immunotherapies
Externí odkaz:
https://doaj.org/article/59e0d1489d4f43e8bdb2660661d4727d
Autor:
Hélène Goussault, Sébastien Gendarme, Jean‐Baptiste Assié, Camille Jung, Salomé Epaud, Christelle Algans, Noémie Salaun‐Penquer, Mathilde Rousseau, Andrea Lazatti, Christos Chouaïd
Publikováno v:
Cancer Medicine, Vol 11, Iss 24, Pp 5025-5034 (2022)
Abstract Background Despite therapeutic advances, lung cancer remains the first cause of death from cancer. The main objective of this study was to identify risk factors associated with death within 3‐months of the first hospitalization for lung ca
Externí odkaz:
https://doaj.org/article/c0e458041f3949f38b24890f428007eb
Autor:
Jean-Baptiste Assié, Christos Chouaïd, Hilario Nunes, Dorothée Reynaud, Anne-Françoise Gaudin, Valentine Grumberg, Ronan Jolivel, Baptiste Jouaneton, François-Emery Cotté, Boris Duchemann
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Up to 10% of patients with advanced non-small cell lung cancer (aNSCLC) have pre-existing interstitial lung disease (ILD). These patients are usually excluded from immunotherapy clinical trials. Consequently, knowledge on outcomes followi
Externí odkaz:
https://doaj.org/article/aaeb77ceaeb54391980a9b65f9f243ac
Autor:
Jonas Poucineau, Tristan Delory, Nathanaël Lapidus, Gilles Hejblum, Christos Chouaïd, Sophie Le Cœur, Myriam Khlat
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundA global reduction in hospital admissions for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) was observed during the first months of the COVID-19 pandemic. Large-scale studies covering the entire pandemic period are l
Externí odkaz:
https://doaj.org/article/cbefce84d5164330b36e91f8656ab69c
Autor:
Paul Lesueur, Alexandre Escande, Juliette Thariat, Enora Vauléon, Isabelle Monnet, Alexis Cortot, Delphine Lerouge, Serge Danhier, Pascal Dô, Catherine Dubos‐Arvis, Christos Chouaïd, Radj Gervais
Publikováno v:
Cancer Medicine, Vol 7, Iss 11, Pp 5505-5513 (2018)
Abstract Introduction Randomized prospective studies on patients with metastatic non‐small‐cell lung cancers (NSCLCs) showed that anti‐programmed death‐1 (PD‐1) agents notably improved 2‐year overall survival (OS) rates, compared to docet
Externí odkaz:
https://doaj.org/article/711a3ee5e82a45f8b0a763e20eabaf20
Autor:
Alain Vergnenegre, Isabelle Monnet, Charles Ricordel, Acya Bizieux, Hubert Curcio, Marie Bernardi, Romain Corre, Florian Guisier, Stéphane Hominal, Gwenaelle Le Garff, Olivier Bylicki, Chrystèle Locher, Margaux Geier, Christos Chouaïd, Gilles Robinet
Publikováno v:
Lung Cancer. 178:191-197
Autor:
Isabelle Monnet, Alain Vergnenègre, Gilles Robinet, Henri Berard, Regine Lamy, Lionel Falchero, Sabine Vieillot, Roland Schott, Charles Ricordel, Stephane Chouabe, Pascal Thomas, Radj Gervais, Anne Madroszyk, Samir Abdiche, Anne Marie Chiappa, Laurent Greillier, Chantal Decroisette, Jean Bernard. Auliac, Christos Chouaïd
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: The role and timing of whole or stereotaxic brain radiotherapy (BR) in patients with advanced non-small cell lung cancer (aNSCLC) and asymptomatic brain metastases (aBMs) are not well established. This study investigates whether deferring
Externí odkaz:
https://doaj.org/article/a1b5190caa744a0094132ccad24a69d7
Autor:
Thierry Landre, Kader Chouahnia, Gaëtan Des Guetz, Boris Duchemann, Jean-Baptiste Assié, Christos Chouaïd
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Introduction: Platin-based chemotherapy (CT) has long been the first-line standard-of-care for patients with extensive-stage small-cell lung cancer (ES–SCLC). Adding immune-checkpoint inhibitor(s) to CT (ICI+CT) in this setting is an option of inte
Externí odkaz:
https://doaj.org/article/98a3806216fe4bb49fd3d4807ffea523